Bavarian Nordic A/S (BVNRY)
11.08
+0.24
(+2.26%)
USD |
OTCM |
Oct 05, 16:00
Bavarian Nordic Enterprise Value : 2.184B for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 2.184B |
| October 02, 2026 | 2.129B |
| October 01, 2026 | 2.123B |
| September 30, 2026 | 2.191B |
| September 29, 2026 | 2.164B |
| September 28, 2026 | 2.188B |
| September 25, 2026 | 2.175B |
| September 24, 2026 | 2.202B |
| September 23, 2026 | 2.216B |
| September 22, 2026 | 2.096B |
| September 21, 2026 | 2.096B |
| September 18, 2026 | 2.076B |
| September 17, 2026 | 2.065B |
| September 16, 2026 | 2.004B |
| September 15, 2026 | 2.039B |
| September 14, 2026 | 2.039B |
| September 11, 2026 | 2.053B |
| September 10, 2026 | 2.051B |
| September 09, 2026 | 2.049B |
| September 08, 2026 | 2.123B |
| September 04, 2026 | 2.245B |
| September 03, 2026 | 2.245B |
| September 02, 2026 | 2.266B |
| September 01, 2026 | 2.266B |
| August 31, 2026 | 2.215B |
| Date | Value |
|---|---|
| August 28, 2026 | 2.150B |
| August 27, 2026 | 2.175B |
| August 26, 2026 | 2.230B |
| August 25, 2026 | 2.230B |
| August 24, 2026 | 2.176B |
| August 21, 2026 | 2.138B |
| August 20, 2026 | 1.928B |
| August 19, 2026 | 1.934B |
| August 18, 2026 | 1.877B |
| August 17, 2026 | 1.856B |
| August 14, 2026 | 1.834B |
| August 13, 2026 | 1.783B |
| August 12, 2026 | 1.766B |
| August 11, 2026 | 1.717B |
| August 10, 2026 | 1.717B |
| August 07, 2026 | 1.731B |
| August 06, 2026 | 1.751B |
| August 05, 2026 | 1.751B |
| August 04, 2026 | 1.751B |
| August 03, 2026 | 1.754B |
| July 31, 2026 | 1.738B |
| July 30, 2026 | 1.722B |
| July 29, 2026 | 1.710B |
| July 28, 2026 | 1.710B |
| July 27, 2026 | 1.668B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evaxion AS | 19.38M |
| Genmab A/S | 26.74B |
| Ascendis Pharma A/S | 14.56B |
| Zealand Pharma A/S | 644.22M |
| Agenus, Inc. | 636.69M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 113.83M |
| Revenue (Quarterly) | 315.94M |
| Total Expenses (Quarterly) | 202.11M |
| EPS Diluted (Quarterly) | 0.4995 |
| Gross Profit Margin (Quarterly) | 60.45% |
| Profit Margin (Quarterly) | 36.03% |
| Earnings Yield | 9.40% |
| Operating Earnings Yield | 6.20% |
| Normalized Earnings Yield | 9.073 |